LCMS webinars focusing on MALDI - page 1

Explore how spatial multiomics combining MALDI Imaging, proteomics, transcriptomics, and HiPLEX-IHC reveals new tumor subpopulations linked to chemoresistance and survival in ovarian cancer.

Explore advanced multimodal imaging with MALDI, QCL-based IR, and fluorescence microscopy to achieve ROI-focused molecular insights in complex tissues.

Discover how Shimadzu’s MicrobialTrack software enhances MALDI-TOF MS with genomics-driven algorithms, broader databases, and clearer workflows for faster, more reliable microbial identification.

In this webinar, we will revisit the fundamental principles of MALDI-MS, and explore the latest applications in MALDI-imaging, polymer analysis and introduce Bruker’s newest MALDI-MS, the neofleX.

Discover how integrating surface chemistry with MALDI-MS enhances small molecule drug discovery. Learn new strategies for assay design and high-throughput screening.

Discover how MALDI-TOF MS streamlines impurity ID, boosts throughput, and supports complex biotherapeutic characterization, from PEG-proteins to cell-based assays.

Explore how spatial lipidomics with MALDI MS-Imaging uncovers prostate cancer heterogeneity and links lipid changes to proteomics insights, advancing cancer research workflows.

Explore how MALDI-2 enhances endocannabinoid imaging in brain tissue. Learn how it boosts sensitivity for neuropharmacology and brain injury research.

In this webinar, we will cover some of the basics on what MALDI is and how it can be used as a tool for imaging before exploring MALDI-IHC in more detail including some examples of its implementation.

DeepCyte introduces two pioneering methods which leverage Bruker mass spectrometry technology, HT SpaceM and 13C-SpaceM, that are set to transform drug discovery and precision medicine.